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Background and aim: This study analyzed peripheral blood lymphocyte subsets to determine their role in the etiopathogenesis of IGM.
Materials and methods: This study includes 51 pathologically proven IGM patients (active disease: 26 and in remission: 25) and 28
healthy volunteers. The analyses of lymphocyte subsets were performed by flow cytometric immunophenotyping.
Results: The percentage of T helper lymphocyte of all IGM patients were lower than control groups (p = 0.001). Absolute cytotoxic T
lymphocyte count (p = 0.03), both percentage (p = 0.035) and absolute count (p = 0.002) of the natural killer cells, and both percentage
(p = 0.038) and absolute count (p = 0.008) of natural killer T cells, were higher than the control group. The T helper lymphocyte
percentage of the patients with active disease was lower than the control group (p = 0.0003). The absolute cytotoxic T lymphocyte (p =
0.029) and natural killer T cells (p = 0.012) of the patients with active disease were higher than the control group.
Conclusion: Idiopathic granulomatous mastitis is defined as a localized form of granulomatous disorders. However, the observed
changes in T cells, NK, and NKT cells suggest that there is systemic immune dysregulation in patients with IGM.
Key words: Idiopathic granulomatous mastitis, lymphocyte subsets, autoimmunity, etiopathogenesis

1. Introduction
Idiopathic granulomatous mastitis (IGM), a benign
inflammatory disease, is rarely seen worldwide.
However, it is more frequent in some Middle Eastern
countries such as Turkey, Egypt, and Iran and Asian
countries such as China, India, and Pakistan. Currently,
no etiological factors accused, including autoimmune
disorders, rheumatologic diseases, infectious causes, and
hormonal imbalances, could be proven. Granulomatous
inflammation can be seen in various diseases of the breast,
but the most common form is idiopathic in especially
these countries [1–4].
Remission and relapse of IGM in some patients with
rheumatologic findings, such as arthritis and/or erythema
nodule, suggest autoimmunity and immune dysregulation
[5–11]. Erhan et al. [12] found T lymphocyte domination
in the tissue of IGM patients. Similarly, in the study by
Chen et al. [13], the predominance of CD3+ cells were
detected higher than CD20+ cells in breast granulomatous
tissue immunohistochemically. The high incidence of
some human leukocyte antigens in patients with IGM also
shed light on the etiopathogenesis [14].

Lymphocytes and their products constitute the most
important part of the immune system. The main subgroups
of lymphocytes are T-cells, B-cells, and natural killer (NK)
cells. In order to establish and maintain a normal immune
response, there must be a balance between the lymphocyte
subgroups with regulatory and effector functions. There
are almost no studies on autoimmunity considering it
as an etiologic factor in IGM patients who may have
abnormalities in humoral and cellular immune systems
[15].
In this study, the changes of peripheral blood
lymphocyte subsets in IGM patients and its possible role
in pathogenesis were aimed to be investigated.
2. Methods
2.1. Patients
Between March 2019 and May 2020, 51 patients with
pathologically proven IGM and 28 healthy volunteers, as
the control group, were enrolled. The IGM patients were
divided into active IGM, and in remission IGM according
to the activity of their disease. Active IGM (n: 26) was
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defined as patients with clinically and radiologically
defined lesions with pathological diagnosis, whilst
patients in remission (n: 25) had no clinical or radiological
symptoms and findings except for their former pathological
diagnosis. The criteria defined by Kessler and Wolloch [16]
and detailed by Cohen [17] were used in the pathological
diagnosis.
Demographic data including age, marital status,
whether the birth, the number of children, breastfeeding
history, and use of oral contraception, symptoms, and
signs were noted.
Flow cytometric analysis
The blood samples were collected during the first
admission, before any treatment was administered in active
IGM patients, whereas the samples were collected at least six
months after the termination of treatment in patient with
remission. In order to evaluate the lymphocyte subgroups,
Using EDTA tubes, 2 mL blood samples were collected
from patients and delivered to the pediatric immunology
laboratory. Peripheral blood samples were collected in K2EDTA anticoagulant. One hundred µL of anticoagulated
whole blood was aliquoted into 5 mL polystyrene falcon
flow cytometer tubes (Becton Dickinson, New Jersey,
USA) and stained with antihuman CD3-PE-Cy5, CD4PE, CD8-FITC, CD19-APC, CD16+CD56-PE, CD45APC monoclonal antibodies (Biolegend, San Diego, USA)
at the manufacturer’s recommended concentration. The
tubes were incubated in the dark for 20 min at room
temperature. Red blood cells were lysed by adding 2 mL
1X red blood cells lysis buffer (Biolegend, San Diego, USA)
and incubating in the dark at room temperature for 10
min. Then the tubes were centrifuged for 5 min at 1500
rpm. The cell pellet was washed once and re-suspended in
500 μL cell staining buffer (Biolegend, San Diego, USA).
Lymphocyte subset analysis was performed using a FACS
Aria III flow cytometer (Becton Dickinson, USA) and FACS
Diva v: 6.1.3 Software (Becton Dickinson, New Jersey,
USA) within 24 h. Lymphocyte subsets were identified
from lymphocyte population as Total T cells (CD3+), T
helper cells (CD3+CD4+), cytotoxic T cells (CD3+CD8+),
B cells (CD19+), natural killer cells (NK-CD3-CD16+56+),
and natural killer T cells (NKT-CD3+CD16+56+).
Statistical analysis
SPSS-15 software was used for all statistical analyses.
For numerical data, mean ± standard deviation (SD) or
median (min-max) were used according to the distribution
of data. The Kruskall–Wallis test was used to compare the
ages of the groups. Student t test was used to compare
the means of two independent groups. In comparing the
means of more than two independent groups, one-way
ANOVA was used. At one-way ANOVA, when a significant
difference was found, Tukey post-hoc analysis was used for
comparing groups. In the comparison of categorical data,
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Fischer Exact test was used as the data did not meet the
assumptions required for χ2 test.
An alpha value (p) less than 0.05 was considered
statistically significant.
3. Results
Fifty-one IGM patients, and 28 healthy volunteers as the
control group were enrolled. The median age of patient
and control groups were 37 (26–64 years), and 34 years
(20–52 years) respectively. There was no statistically
significant difference in age between the patients and
healthy volunteers (p = 0.31). Demographic and clinical
features of all the patients enrolled and the treatment
approaches are given in Table 1.
Comparison of control group and all patients’
lymphocyte subsets
The absolute counts of leukocytes, neutrophils and
monocytes in IGM patients were higher than in the
control group. While lymphocyte percentage and T
helper lymphocyte percentage were statistically lower in
the patient group compared to the control, lymphocyte
absolute count, T cytotoxic lymphocyte absolute count,
natural killer cell percentage and absolute count and
natural killer T cell percentage and absolute count were
statistically higher in the patient group compared to the
control group. T lymphocyte count and percentage, T
helper lymphocyte absolute count, T cytotoxic lymphocyte
percentage, total B lymphocyte percentage and absolute
count, and double negative T cell percentage and absolute
count were similar between the two groups. In addition,
the CD4/CD8 ratio was found to be statistically lower
in the patient group compared to the control group. The
absolute count and percentage of leukocytes, neutrophils,
monocytes, lymphocytes, the lymphocyte subset values,
and CD4/CD8 ratio were given in Table 2.
The comparisons of control group and the subgroups
of patients
The absolute count and percentages of leukocytes,
neutrophils, monocytes, and lymphocytes, the
lymphocyte subset values of the control group and the
subgroups of IGM patients were given in Table 3. The
leukocyte counts and absolute counts of neutrophils, T
cytotoxic lymphocytes, NK and NKT cells were higher in
patients with active IGM disease than the control group.
The percentages of neutrophils, T cytotoxic lymphocytes,
NK and NKT cells were also statistically higher in patients
with active IGM than the control group (Table 3). The
percentages of lymphocytes and T helper lymphocytes
were statistically lower in patients with active disease than
the control group. CD4/CD8 ratio was lower in patients
with active disease when compared with the control
group.
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Table 1. The patients’ clinical features.
With active disease
(n = 26)

In remission†
(n = 25)

p-value

Nulliparous

0 (0)

1 (4)

0.999

Parous

25 (100)

24 (96)

Breastfeeding history*

25 (100)

24 (96)

0.999

Oral contraceptive use history

3 (12)

7 (28)

0.15

Smoking*

2 (8)

3 (12)

0.999

Premenopausal

23 (92)

25 (100)

0.49

Postmenopausal

2 (8)

0

Mass*

25 (100)

24 (96)

0.66

Pain*

23 (92)

21 (84)

0.999

Erythema

16 (64)

16 (64)

0.999

Abscess

12 (48)

15 (60)

0.39

Axillary lymphadenopathy

13 (52)

8 (32)

0.25

Peau d’orange

2 (8)

2 (8)

0.999

Nipple retraction*

0

4 (16)

0.11

Ulcer*

3 (12)

2 (8)

0.999

Fistula*

0

3 (12)

0.11

Erythema nodosum*

1 (4)

3 (12)

0.6

Treatment approaches

**

Parity status*

Menopausal status*

Symptom and signs

Wait and watch

3 (12)

Only antibiotics

4 (16)

Drainage + antibiotics

9 (36)

Intralesional steroid

5 (20)

Systemic steroid

3 (12)

Topical and intralesional steroid

1 (4)

† For idiopathic granulomatous mastitis patients in remission clinical features at the time of first diagnosis
are given. At the time of study these patients had no symptoms or findings.
*These categorical data applied to Fisher Exact test.
** Treatment approaches of active IGM patients were not given because the blood samples were collected
during the first admission, before any treatment in these patients.

4. Discussion
Although some infectious causes and autoimmune
processes, diabetes mellitus, and sarcoidosis can cause
granulomatous reactions, the most common form of
granulomatous inflammation in the breast is idiopathic
[1]. In the present, the etiology of IGM is not clear.
However, different factors including the deficiency
of alpha-1 antitrypsin, oral contraceptives, smoking,
hyperprolactinemia, ethnicity, autoimmunity, gestation,
and birth and breast-feeding have been thought to be
involved in the etiopathogenesis of IGM [1,2]. Recently,

autoimmunity and immune dysregulation have been
emphasized, but studies on this subject are limited.
Some patients with IGM respond well to
immunosuppressive drugs such as steroids and
methotrexates; the presence of extramammary findings
likes erythema nodosum or arthritis in some patients and
some recent studies, although limited, suggest that more
emphasis should be given to autoimmunity and immune
dysregulation in IGM [3–13]. The aim of our study was
to investigate the number of T and B lymphocytes and
changes in NK and NKT cells in IGM patients.
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Table 2. The patients and control groups’ lymphocyte subsets.
MAIN GROUPS
All IGM patients
(n=51)

Control groups
(n=28)

p

8810.4 ± 2694.8

6824.2 ±1583.9

.001

%

61.46 ± 7.64

57.61± 5.08

.019

Absolute counts

5530.1 ± 2096.3

3946.3 ± 1020.3

< .0001

Absolute counts

530.7 ± 258.9

408.2 ± 116.4

.005

%

5.91 ± 1.52

6.07 ± 1.51

.64

%

27.85 ± 7.04

31.22 ± 5.22

.015

Absolute counts

2362.72 ± 702.99

2119.61 ± 531.82

.11

%

74.22 ± 7.97

77.53 ± 5.56

.055

Absolute counts

1742.44 ± 513.46

1641.78 ± 420.49

.38

%

42.87 ± 7.67

48.83 ± 5.56

.001

Absolute counts

1008.05 ± 343.49

1033.74 ± 275.30

.73

%

25.08 ± 6.13

23.05 ± 5.23

.14

Absolute counts

585.51 ± 196.45

488.78 ± 175.81

.03

%

13.9 ± 6.95

10.74 ± 4.7

.035

Absolute counts

332.88 ± 190.03

225.76 ± 104.5

.002

%

9.64 ± 3.86

9.16 ± 3.75

.59

Absolute

228.85 ± 127.1

200.63 ± 110.96

.32

%

5.92 ± 3.41

4.53 ± 2.38

.038

Absolute counts

144.33 ± 111.11

94.17 ± 49.95

.008

%

6.38 ± 3.48

5.64 ± 3.14

.35

Absolute counts

151.58 ± 91.59

119.34 ± 71.22

.11

CD4/CD8 ratio

1.85 ± 0.77

2.26 ± 0.74

.023

Leukocyte counts
Neutrophil

Monocyte

Lymphocyte

Lymphocyte subsets
Total T lymphocyte

T helper lymphocyte

T cytotoxic lymphocyte

Natural killer cells

Total B lymphocyte

Natural killer T cell

Double negative T cells

In the study by Altıntoprak et al. [3], they investigated
the autoantibodies including ANA and ENA levels in IGM.
However, the authors could not demonstrate any relationship
between autoimmunity and IGM. In another important
study, the authors serologically examined rheumatoid
factor, ANA and anti-dsDNA in eight patients with IGM.
Rheumatoid factor positivity was detected in 6 patients and
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ANA and anti-ds DNA positivity were detected in 2 patients.
In these two patients, rheumatoid factor, ANA, and anti-ds
DNA were all positive [18]. Unfortunately, in our article on
autoantibodies in IGM, the newly online ahead of print, our
findings did not support the clinical utility of autoantibodies
including RF, ANA, anti-ds-DNA, pANCA and anti-CCP in
IGM neither in diagnosis nor in follow up [19].
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Table 3. The subgroups and control groups’ hematological parameters and lymphocyte subsets.
SUBGROUPS
With active disease
(n=26)

In remission
(n=25)

Control groups
(n=28)

p

9545.0 ± 2214.8

8077.0 ± 2995.0

6824.2 ±1583.9

< .0001a

%

63.58 ± 7.68

5979.0 ± 6.69

57.61 ± 5.08

.005b

Absolute counts

6093.2 ± 1744.4

4920.25 ± 2304.4

3946.3 ± 1020.3

<.0001c

%

5.59 ± 1.67

6.21 ± 1.33

6.07 ± 1.51

.277

Absolute counts

543.7 ± 229.5

516.6 ± 291.9

408.2 ± 116.4

.06

%

26.5 ± 6.72

29.26 ± 7.22

31.22 ± 5.22

.02d

Absolute counts

2503.5 ± 800.7

2210.21 ± 556.16

2119.61 ± 531.82

.08

%

74.03 ± 6.84

74.42 ± 9.15

77.53 ± 5.56

.15

Absolute counts

1833.62 ± 537.6

1643.67 ± 477.45

1641.78 ± 420.49

.25

%

41.9 ± 5.85

43.89 ± 9.21

48.83 ± 5.56

.002e

Absolute counts

1047.13 ± 346.91

965.72 ± 342.0

1033.74 ± 275.30

.64

%

25.57 ± 6.01

24.58 ± 6.34

23.05 ± 5.23

.28

Absolute counts

624.4 ± 210.78

543.37 ± 174.26

488.78 ± 175.81

.03f

%

13.5 ± 6.54

14.27 ± 7.46

10.74 ± 4.7

.1

Absolute counts

347.72 ± 208.59

316.82 ± 170.66

225.76 ± 104.5

.02g

%

9.47 ± 4.43

9.82 ± 3.25

9.16 ± 3.75

.82

Absolute counts

240.44 ± 154.84

216.31 ± 89.66

200.63 ± 110.96

.48

%

6.65 ± 3.36

5.16 ± 3.36

4.53 ± 2.38

.039 h

Absolute counts

168.36 ± 104.73

118.3 ± 114.1

94.17 ± 49.95

.015i

%

6.81 ± 3.7

5.92 ± 3.25

5.64 ± 3.14

.42

Absolute counts

167.85 ± 96.54

133.97 ± 84.38

119.34 ± 71.22

.1

CD4/CD8 ratio

1.74 ± 0.55

1.96 ± 0.94

2.26 ± 0.74

.045j

Leukocyte counts
Neutrophil

Monocyte

Lymphocyte

Lymphocyte subsets
Total T lymphocyte

T helper lymphocyte

T cytotoxic lymphocyte

Natural killer cells

Total B lymphocyte

Natural killer T cell

Double negative T cells

With active disease & control group, p < .00001.
With active disease & control group, p = 0.004.
c
With active disease & control group, p < 0.0001.
d
With active disease & control group, p = 0.033.
e
With active disease & control group, p = 0.0003; in remission & control groups, p = 0.054.
f
With active disease & control group, p = 0.029.
g
With active disease & control group, p = 0.023.
h
With active disease & control group, p = 0.034.
i
With active disease & control groups, p = 0.012.
j
With active disease & control groups, p = 0.036.
a

b
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In a very important study by Erhan et al. [12], the
authors investigated T and B lymphocyte markers in biopsy
specimens in patients with IGM. In this study, T lymphocyte
predominance was observed in biopsy specimens. Similarly,
in the study by Chen et al. [13], the predominance of CD3+
cells were detected higher than CD20+ cells in breast
granulomatous tissue immunohistochemically.
In our previous study, cytokine changes in patients
with IGM were examined. The levels of interleukins -8,
-10, and -17 in patients with IGM were found to be higher
than the controls. We concluded that interleukins-8 and
-17, proinflammatory cytokines, could have a role in the
pathogenesis of IGM, but the low interleukin-10 levels
suggested the reduction in the release of proinflammatory
cytokines as well as suppressing their function. Therefore,
it contributes to controlling the extent of disease [20].
Granulomatous inflammation, a form of delayed type
hypersensitivity reaction, is a protective response to chronic
infections with persistent pathogens such as mycobacterial
infections. Granuloma formation may appear as a
primary lesion in cases where the cause is unknown, as in
sarcoidosis or IGM. In addition, the important role of T
helper cells in granuloma formation is well known [21].
Similar findings were found in the studies by Erhan et al.
[12] and Chen et al. [13]. In our study, T helper cell ratio of
all the IGM patients were lower than the control group. In
subgroups analyses, T helper cell ratio of the patients with
active disease was lower. Recruitment of T helper cells in
granulomatous breast tissue may be a reason of low T cells
in peripheral blood of the patients.
The role of T cytotoxic cells in some granuloma
formation including listeriosis is known and T cytotoxic
cells’ accumulation are shown in effector phase of granuloma
formation [22]. In this experimental study, listeriosis
leading to rapid activation, proliferation and apoptosis of
CD4 + and CD8 + T cells were revealed. In another study
by Mannering and Cheers, chronic Mycobacterium avium
infection was found to be associated with an increase in
T-cell apoptosis and elevated, but sustained levels of in
vivo proliferation [23]. In our study, absolute cytotoxic T

cell count was found to be high in active IGM patients.
This increase of T cytotoxic cells and the change of CD4/
CD8 ratio may be related to a decrease in T helper cells. The
limitation of our study was the lack of longitudinal followup of lymphocyte subsets in active patients.
Natural killer T cells play an important role in
suppressing granuloma formation in the liver of mice by
modulating the production of IFN-ɣ and IL-10. In this
experimental study, they revealed increased granuloma
formation in mice without NKT cells, which may be
explained by an increased interferon gamma production.
As a result, NKT cells were found to suppress granuloma
formation [24]. We found that the NK cells and NKT cells
were higher in IGM patients than the control group. The
present results suggest that NKT cells may play a role in
regulating and/or suppressing granuloma formation.
In conclusion, understanding the regulatory capacity
of T cell subsets and NK cells in granuloma formation in
IGM may allow understanding of the etiophatogenesis and
lead to the development of new therapeutic agents for this
disease which is full of secrets.
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